BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33272782)

  • 1. Discovery of tetrahydroquinolines and benzomorpholines as novel potent RORγt agonists.
    Xia Y; Yu M; Zhao Y; Xia L; Huang Y; Sun N; Song M; Guo H; Zhang Y; Zhu D; Xie Q; Wang Y
    Eur J Med Chem; 2021 Feb; 211():113013. PubMed ID: 33272782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases.
    Sun N; Ma X; Zhou K; Zhu C; Cao Z; Wang Y; Xu J; Fu W
    Eur J Med Chem; 2020 Feb; 187():111984. PubMed ID: 31881455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel N-sulfonamide-tetrahydroisoquinolines as potent retinoic acid receptor-related orphan receptor γt agonists.
    Ma X; Sun N; Li X; Fu W
    Eur J Med Chem; 2021 Oct; 222():113585. PubMed ID: 34118722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Substituted quinolines as RORγt inverse agonists.
    Barbay JK; Cummings MD; Abad M; Castro G; Kreutter KD; Kummer DA; Maharoof U; Milligan C; Nishimura R; Pierce J; Schalk-Hihi C; Spurlino J; Tanis VM; Urbanski M; Venkatesan H; Wang A; Woods C; Wolin R; Xue X; Edwards JP; Fourie AM; Leonard K
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5277-5283. PubMed ID: 29079472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel triazine derivatives as potent retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonists.
    Lu L; Chen S; Yu M; Zhou R; Guo S; Chen JA; Wang H; Chen S; Luo C; Xie Q; Wang Y
    Eur J Med Chem; 2023 Aug; 256():115424. PubMed ID: 37167779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of aryl-substituted indole and indoline derivatives as RORγt agonists.
    Zhu Y; Sun N; Yu M; Guo H; Xie Q; Wang Y
    Eur J Med Chem; 2019 Nov; 182():111589. PubMed ID: 31425906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists.
    Sun N; Huang Y; Yu M; Zhao Y; Chen JA; Zhu C; Song M; Guo H; Xie Q; Wang Y
    Eur J Med Chem; 2020 Sep; 202():112536. PubMed ID: 32698100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of carbazole carboxamides as novel RORγt inverse agonists.
    Huang Y; Yu M; Sun N; Tang T; Yu F; Song X; Xie Q; Fu W; Shao L; Wang Y
    Eur J Med Chem; 2018 Mar; 148():465-476. PubMed ID: 29477887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of N-indanyl benzamides as potent RORγt inverse agonists.
    Tian J; Sun N; Yu M; Gu X; Xie Q; Shao L; Liu J; Liu L; Wang Y
    Eur J Med Chem; 2019 Apr; 167():37-48. PubMed ID: 30743096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Evaluation of Retinoic Acid-Related Orphan Receptor γt (RORγt) Agonist Structure-Based Functionality Switching Approach from In House RORγt Inverse Agonist to RORγt Agonist.
    Yukawa T; Nara Y; Kono M; Sato A; Oda T; Takagi T; Sato T; Banno Y; Taya N; Imada T; Shiokawa Z; Negoro N; Kawamoto T; Koyama R; Uchiyama N; Skene R; Hoffman I; Chen CH; Sang B; Snell G; Katsuyama R; Yamamoto S; Shirai J
    J Med Chem; 2019 Feb; 62(3):1167-1179. PubMed ID: 30652849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists.
    Wang Y; Yang T; Liu Q; Ma Y; Yang L; Zhou L; Xiang Z; Cheng Z; Lu S; Orband-Miller LA; Zhang W; Wu Q; Zhang K; Li Y; Xiang JN; Elliott JD; Leung S; Ren F; Lin X
    Bioorg Med Chem; 2015 Sep; 23(17):5293-302. PubMed ID: 26277758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists.
    Fauber BP; Gobbi A; Savy P; Burton B; Deng Y; Everett C; La H; Johnson AR; Lockey P; Norman M; Wong H
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4109-13. PubMed ID: 26321361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of tert-amine-based RORγt agonists.
    Qiu R; Yu M; Gong J; Tian J; Huang Y; Wang Y; Xie Q
    Eur J Med Chem; 2021 Nov; 224():113704. PubMed ID: 34303081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of betulinaldehyde as a natural RORγt agonist.
    Yang F; Zhang R; Ni D; Luo X; Chen S; Luo C; Xiao W
    Fitoterapia; 2019 Sep; 137():104200. PubMed ID: 31195082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt.
    Kummer DA; Cummings MD; Abad M; Barbay J; Castro G; Wolin R; Kreutter KD; Maharoof U; Milligan C; Nishimura R; Pierce J; Schalk-Hihi C; Spurlino J; Urbanski M; Venkatesan H; Wang A; Woods C; Xue X; Edwards JP; Fourie AM; Leonard K
    Bioorg Med Chem Lett; 2017 May; 27(9):2047-2057. PubMed ID: 28318945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanism of Action of RORγt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation.
    Sun N; Yuan C; Ma X; Wang Y; Gu X; Fu W
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30513894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of carbazole carboxamide RORγt agonists: Challenges in improving the metabolic stability and maintaining the agonistic activity.
    Sun N; Yu M; Jiang Z; Yang F; Lu L; Xia Y; Zhao Y; Huang Y; Chen S; Chen S; Luo C; Wang Y; Xie Q
    Eur J Med Chem; 2023 May; 251():115213. PubMed ID: 36905917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonists.
    Ruan Z; Park PK; Wei D; Purandare A; Wan H; O'Malley D; Stachura S; Perez H; Cavallaro CL; Weigelt CA; Sack JS; Ruzanov M; Khan J; Gururajan M; Wong JJ; Huang Y; Yarde M; Li Z; Chen C; Sun H; Borowski V; Xie JH; Anthony M; Agler M; Fink BE; Harikrishnan LS
    Bioorg Med Chem Lett; 2021 Mar; 35():127778. PubMed ID: 33422603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Biaryl Amide Derivatives as Potent, Selective, and Orally Bioavailable RORγt Agonists for Cancer Immunotherapy.
    Lu L; Huang Y; Song M; Sun N; Xia L; Yu M; Zhao M; Qiu R; Chen JA; Zhao Y; Wang H; Guo H; Li Y; Zhu D; Wang Y; Xie Q
    J Med Chem; 2023 Dec; 66(23):16091-16108. PubMed ID: 37982494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist Lock Touched and Untouched Retinoic Acid Receptor-Related Orphan Receptor-γt (RORγt) Inverse Agonists: Classification Based on the Molecular Mechanisms of Action.
    Sun N; Xie Q; Dang Y; Wang Y
    J Med Chem; 2021 Aug; 64(15):10519-10536. PubMed ID: 34264059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.